Better Therapeutics, Inc.

Mountain Crest Acquisition Corp. II (Nasdaq: MCAD), sponsored by Mountain Crest Capital LLC, completed its initial public offering in early 2021 targeting the healthcare technology sector. The company filed an amended quarterly report, Form 10-Q/A, on June 28, 2021, around the time it announced a planned business combination with Better Therapeutics, Inc., a developer of prescription digital therapeutics for cardiometabolic conditions. Better Therapeutics uses software-based interventions as regulated medical treatments. The transaction closed later in 2021, converting MCAD into an operating digital health company. Sign up at SpacDesk for complete deal data, filing history, and analytics on MCAD and the broader SPAC market.